It was observed that tumor size, volume, and weight were smaller in the group with MARCKSL1–2 overexpression or DTX treatment than those in the control group, and MARCKSL1–2 overexpression induced further reduction in the above parameters in groups with DTX treatment (Figs. 7a-c). This evidence concerns the gene MARCKSL1 and neoplasm.